FKBP Ligands as Novel Therapeutics for Neurological Disorders
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
377-397
Author(s):
C. Christner, T. Herdegen and G. Fischer
Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
225-238
Author(s):
J. Garcia de Yebenes and M. P. Sanchez
Neuroprotective Mechanisms as Treatment Strategy in Alzheimers disease
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
239-246
Author(s):
Agneta Nordberg
Elucidating Neuronal and Vascular Injury Through the Cytoprotective Agent Nicotinamide
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
257-267
Author(s):
Kenneth Maiese, Shi-Hua Lin and Zhao Zhong Chong
The Hereditary Disease Array Group (HDAG) - Microarrays, Models and Mechanisms : A Collaboration Update
Journal:
Current Genomics
Volume:
2
Page:
221-229
Author(s):
Tim- Rasmus Kiehl, James M. Olson and Stefan M. Pulst
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
synthesis and Structure-Activity Relationships of 2,3-Benzodiazepines as AMPA Receptor Antagonists
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
243-253
Author(s):
M. Zappala, S. Grasso, N. Micale, S. Polimeni and C. De Micheli
Development of Neurotrophic Molecules for Treatment of Neurode-generation
Journal:
Current Protein & Peptide Science
Volume:
2
Page:
261-276
Author(s):
Zhe-yu Chen, Li Cao, Li-mei Wang, Chao Guo, Jun-Li Ye, Yan-Feng Chai and Zhi-Yong Yan
Design of NAALADase Inhibitors A Novel Neuroprotective Strategy
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
949-957
Author(s):
Paul F. Jackson and Barbara S. Slusher
Targeting the Expression of Anti-Apoptotic Proteins by Antisense Oligonucleotides
Journal:
Current Drug Targets
Volume:
2
Page:
167-180
Author(s):
Nicholas Delihas